Skip to content

Clinical trials

Cutaneous Squamous Cell Carcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cutaneous Squamous Cell Carcinoma Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20193
20203
20213
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals4
Incyte Corporation2
Melanoma Institute Australia2
Bicara Therapeutics1
Checkpoint Therapeutics, Inc.1
Medicenna Therapeutics, Inc.1
Merck Sharp & Dohme LLC1
Peter MacCallum Cancer Centre, Australia1
Replimune, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cutaneous Squamous Cell Carcinoma14
Carcinoma, Merkel Cell5
Basal Cell Carcinoma4
Endometrial Neoplasms3
Melanoma3
Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Ovarian Epithelial2
Carcinoma, Renal Cell2

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.